Similar articles

• Humoral immune response to alpha-methylacyl-CoA racemase and prostate cancer.

  Sreekumar A, Laxman B, Rhodes DR, Bhagavathula S, Harwood J, Giacherio D, Ghosh D, Sanda MG, Rubin MA, Chinnaiyan AM. Sreekumar A, et al. J Natl Cancer Inst. 2004 Jun 2;96(11):834-43. doi: 10.1093/jnci/djh145. J Natl Cancer Inst. 2004. PMID: 15173267
• [Emerging biomarkers for the diagnosis, staging and prognosis of prostate cancer].

  Mazzola CR, Ghoneim T, Shariat SF. Mazzola CR, et al. Prog Urol. 2011 Jan;21(1):1-10. doi: 10.1016/j.purol.2010.07.004. Epub 2010 Aug 14. Prog Urol. 2011. PMID: 21193139 Review. French.
• Detection of alpha-methylacyl-coenzyme-A racemase transcripts in blood and urine samples of prostate cancer patients.

  Zehentner BK, Secrist H, Zhang X, Hayes DC, Ostenson R, Goodman G, Xu J, Kiviat M, Kiviat N, Persing DH, Houghton RL. Zehentner BK, et al. Mol Diagn Ther. 2006;10(6):397-403. doi: 10.1007/BF03256217. Mol Diagn Ther. 2006. PMID: 17154657
• [Related biomarkers in the diagnosis of prostate cancer].

  Xu YM, Liu HZ. Xu YM, et al. Zhonghua Nan Ke Xue. 2015 Oct;21(10):937-40. Zhonghua Nan Ke Xue. 2015. PMID: 26665686 Review. Chinese.
• P504S expressing circulating prostate cells as a marker for prostate cancer.

  Murray NP, Calaf GM, Badinez L, Dueñas R, Badinez O, Orellana N, Reyes E, Fuentealba C. Murray NP, et al. Oncol Rep. 2010 Sep;24(3):687-92. doi: 10.3892/or_00000908. Oncol Rep. 2010. PMID: 20664974